Routine Tests for Hearing Loss in All Cisplatin-Treated Patients

More than half of patients treated with cisplatin-based chemotherapy develop hearing loss or tinnitus, which can be devastating, say researchers who urge that all patients should be tested routinely.
Medscape Medical News

source https://www.medscape.com/viewarticle/987469?src=rss